Interactions Between Signaling Pathways
mTOR Signaling and Cancer Progression
mTOR Signaling and Cancer Progression
TGF - β Signaling Pathway
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Jul 13, 2026
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=75)
Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)
Published on: December 19, 2019
Mete Erdogan1, Ambra Pozzi, Neil Bhowmick
1Department of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA.
TC21 (R-Ras2) overexpression drives cancer progression by activating key signaling pathways like PI3K and mTOR. These transformed cells become resistant to TGF-beta
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: